. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Botulinum Toxins, Type A/adverse effectsBotulinum Toxins, Type A/economicsBotulinum Toxins, Type A/therapeutic useChronic DiseaseDrug CostsHumansMigraine Disorders/prevention & controlNeuromuscular Agents/adverse effectsNeuromuscular Agents/economicsNeuromuscular Agents/therapeutic useRandomized Controlled Trials as Topic
Substances： See more » Neuromuscular AgentsBotulinum Toxins, Type A
Year: 2011 PMID： 21252842
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN： 0025-732X Impact factor: 1.909